and the FSNP after UV irradiation. The intensity from the
PC-FSNP decreased considerably compared to that of the
FSNP, which had no major changes in fluorescence under either
UV or visible light. Furthermore, the intensity was reversibly
changed by repeatedly irradiating with UV and visible light up
to 8 times (Fig. 4b). The average intensity difference between
UV and visible light irradiation was 48.1 Æ 1.7%, which is
similar to the quenching efficiency of PC-FSNP (52%) in an
aqueous solution. It is noteworthy that the photoreversible
reaction of the PC-FSNP occurred consistently in both the
pristine solution and the intracellular environment.
In conclusion, we prepared photoreversibly switchable
photoluminescent nanoparticles through the conjugation of
an amine-functionalised photochrome, C60, and silica by the
reverse microemulsion method. The PL of the nanoparticles
was reversibly and repeatedly switched on and off upon UV
and visible light irradiation through the intermolecular energy
transfer between the photo-induced transformation of PC and
C60–O–Si, the PL species. The quenching efficiency (about 50%)
of PC-FSNP by UV irradiation in both a pristine solution and
an intracellular environment was comparable to that of other
photoreversible switching systems. This nanosystem consisted
of a photoswitchable molecule and a rigid, photostable and
biocompatible photoluminescent moiety could be used for
photoreversible analysis during cellular imaging and detection
of target molecules in a complex biological system with a high
signal-to-noise ratio.
Fig. 4 (a) Fluorescence images of PC-FSNP-containing HeLa cells.
The images were taken under a combination of 490 nm excitation/617 nm
emission filter after UV and visible light irradiation for 5 min each.
(b) Comparison of fluorescence intensity of PC-FSNP and FSNP
under repeatable UV and visible light irradiation.
moiety to the C60 through the tetraethyleneglycol linker, which
is close enough for energy transfer to occur (o5 nm). Compared
to the quenching efficiency of FRET and other systems,
PC-FSNP is a reasonable system for photoreversible analysis
or imaging owing to its rigid structure surrounding the photo-
transformation moiety, its high photostability, and the bio-
compatibility originating from the FSNP.
The authors acknowledge the financial support received from
the Pioneer Research Center Program (Grant No. 2008-00180,
MEST, Korea), the Fundamental R&D Program for Core
Technology (MKE, Korea), and the KRIBB Initiative Program
(KRIBB).
Notes and references
In light of these advantages, we evaluated the photoreversible
cellular imaging of PC-FSNP uptake in cells with sequential
UV and visible light irradiation. Before the cellular imaging, we
investigated the time-dependent quenching effects of PC-FSNP
to determine an adequate irradiation time. The relative fluores-
cence intensity of the PC-FSNP in an aqueous solution was
measured every minute after either UV or visible light irradiation.
As seen in Fig. S4 (ESIw), the intensities after UV irradiation
gradually decreased by almost 50%, while the intensities after
visible irradiation increased within 5 min. After 5 min, there
were no further changes in either the quenching or recovery of
the PL of the PC-FSNP. Therefore, the irradiation time for the
photoreversible effect of the PC-FSNP was fixed at 5 min.
For cellular imaging, the HeLa cells were incubated with
PC-FSNP and FSNP (50 mg mlÀ1 for each) for cellular uptake
by endocytosis. Next, the cells were washed with the media
and PBS after one-hour incubation. The fluorescent images of
the nanoparticle-containing cells were obtained by fluores-
cence microscopy with an emission filter of 617 nm under
excitation at 488 nm. As seen in Fig. 4a, both the PC-FSNP-
and FSNP-containing cells showed bright red emission in the
cytosol region of the cells after visible light irradiation,
indicating that both the PC-FSNPs and FSNPs were signifi-
cantly internalised into the cells. However, there was a distin-
guishable difference in the red fluorescence of the PC-FSNP
1 M. Ferrari, Nat. Rev. Cancer, 2005, 5, 161–171.
2 H. Amrania, A. P. McCrow, M. R. Matthews, S. G. Kazarian,
M. K. Kuimova and C. C. Phillips, Chem. Sci., 2011, 2, 107–111.
3 X. Michalet, F. Pinaud, L. Bentolila, J. Tsay, S. Doose, J. Li,
G. Sundaresan, A. Wu, S. Gambhir and S. Weiss, Science, 2005,
307, 538.
4 S. N. Baker and G. A. Baker, Angew. Chem., Int. Ed., 2010, 49,
6726–6744.
5 J. I. Morgan, A. Dubra, R. Wolfe, W. H. Merigan and
D. R. Williams, Invest. Ophthalmol. Visual Sci., 2008, 50,
1350–1359.
6 Z. Liu, S. Tabakman, S. Sherlock, X. Li, Z. Chen, K. Jiang, S. Fan
and H. Dai, Nano Res., 2010, 3, 222–233.
7 M. Q. Zhu, L. Zhu, J. J. Han, W. Wu, J. K. Hurst and A. D. Q. Li,
J. Am. Chem. Soc., 2006, 128, 4303–4309.
8 F. Alexis, E. Pridgen, L. K. Molnar and O. C. Farokhzad, Mol.
Pharmaceutics, 2008, 5, 505–515.
9 M. Irie, O. Miyatake, K. Uchida and T. Eriguchi, J. Am. Chem.
Soc., 1994, 116, 9894–9900.
10 S. H. Kawai, S. L. Gilat, R. Ponsinet and J.-M. Lehn, Chem.–Eur.
J., 1995, 1, 285–293.
11 H. Tian and S. Yang, Chem. Soc. Rev., 2004, 33, 85–97.
12 I. Yildiz, E. Deniz and F. M. Raymo, Chem. Soc. Rev., 2009, 38,
1859–1867.
13 J. Jeong, M. Cho, Y. T. Lim, N. W. Song and B. H. Chung, Angew.
Chem., Int. Ed., 2009, 48, 5296–5299.
14 R. Seshadri, A. Govindraj and C. N. R. Rao, Fullerene Sci.
Technol., 1993, 1, 547–556.
15 F. M. Raymo and M. Tomasulo, J. Phys. Chem. A, 2005, 109,
7343–7352.
c
10670 Chem. Commun., 2011, 47, 10668–10670
This journal is The Royal Society of Chemistry 2011